Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia-Reference-Cited by-同舟云学术

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

Published:2015-05-26 Issue:11 Volume:4 Page:e1027469
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Dai Hanren,Zhang Wenying,Li Xiaolei,Han Qingwang,Guo Yelei,Zhang Yajing,Wang Yao,Wang Chunmeng,Shi Fengxia,Zhang Yan,Chen Meixia,Feng Kaichao,Wang Quanshun,Zhu Hongli,Fu Xiaobing,Li Suxia,Han Weidong

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1027469

Reference58 articles.

1. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

2. The myth of the second remission of acute leukemia in the adult

3. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia

4. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia

5. Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy;Blood Advances;2024-05-30

2. Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia;Haematologica;2024-05-10

3. The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management;Advanced Pharmaceutical Bulletin;2024-03-10

4. Adoptive cellular therapy after hematopoietic stem cell transplantation;American Journal of Hematology;2024-01-25

5. Optimisation of a primary human CAR‐NK cell manufacturing pipeline;Clinical & Translational Immunology;2024-01